-
公开(公告)号:EP2220220A1
公开(公告)日:2010-08-25
申请号:EP08857829.9
申请日:2008-12-02
发明人: SVENDSEN, Allan , BEIER, Lars , LARSEN, Signe, Eskildsen , LENHARD, Thomas , KJAER, Tanja, Maria, Rosenkilde , GREGORY, Peter, Colin
CPC分类号: C12N9/52 , A61K38/00 , A61K38/465 , A61K38/47 , A61K2300/00
摘要: The invention relates to novel variants of a protease derived from Nocardiopsis sp. (SEQ I D NO: 1 ) and closely related proteases, as well as their pharmaceutical use. The variants show improved performance in the treatment of pancreatic exocrine insufficiency (PEI). The variants may be combined with a lipase and/or an amylase. Other examples of medical indications are: Treatment of digestive disorders, pancreatitis, cystic fibrosis, diabetes type I, and/or diabetes type II.
-
公开(公告)号:EP2315841A1
公开(公告)日:2011-05-04
申请号:EP09807924.7
申请日:2009-08-14
申请人: Novozymes A/S
CPC分类号: C12Q1/02 , C12Q1/533 , G01N2333/99
摘要: The invention provides methods of screening a microbial host cell for a property of interest in a microfluidic device, the method comprising the steps of: a) transforming a d-alanine racemase-deficient microbial host cell with a polynucleotide construct comprising: i) one or more polynucleotide region providing the property of interest when present in the host cell, and ii) at least one polynucleotide region complementing the d-alanine racemase deficiency when present in the host cell; and b) screening the transformed host cell for the property of interest in the microfluidic device in the absence of externally provided d-alanine.
-
公开(公告)号:EP2315841B1
公开(公告)日:2012-08-08
申请号:EP09807924.7
申请日:2009-08-14
申请人: Novozymes A/S
CPC分类号: C12Q1/02 , C12Q1/533 , G01N2333/99
摘要: The invention provides methods of screening a microbial host cell for a property of interest in a microfluidic device, the method comprising the steps of: a) transforming a d-alanine racemase-deficient microbial host cell with a polynucleotide construct comprising: i) one or more polynucleotide region providing the property of interest when present in the host cell, and ii) at least one polynucleotide region complementing the d-alanine racemase deficiency when present in the host cell; and b) screening the transformed host cell for the property of interest in the microfluidic device in the absence of externally provided d-alanine.
-
-